Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
Crossref DOI link: https://doi.org/10.1186/s12902-016-0116-8
Published Online: 2016-06-09
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Farshchi, Amir
Aghili, Rokhsareh
Oskuee, Maryam
Rashed, Marjan
Noshad, Sina
Kebriaeezadeh, Abbas
Kia, Maryam
Esteghamati, Alireza
Funding for this research was provided by:
NovoNordisk Pars